Literature DB >> 17386262

A minimal TrpRS catalytic domain supports sense/antisense ancestry of class I and II aminoacyl-tRNA synthetases.

Yen Pham1, Li Li, Aram Kim, Ozgun Erdogan, Violetta Weinreb, Glenn L Butterfoss, Brian Kuhlman, Charles W Carter.   

Abstract

The emergence of polypeptide catalysts for amino acid activation, the slowest step in protein synthesis, poses a significant puzzle associated with the origin of biology. This problem is compounded as the 20 contemporary aminoacyl-tRNA synthetases belong to two quite distinct families. We describe here the use of protein design to show experimentally that a minimal class I aminoacyl-tRNA synthetase active site might have functioned in the distant past. We deleted the anticodon binding domain from tryptophanyl-tRNA synthetase and fused the discontinuous segments comprising its active site. The resulting 130 residue minimal catalytic domain activates tryptophan. This residual catalytic activity constitutes the first experimental evidence that the conserved class I signature sequences, HIGH and KMSKS, might have arisen in-frame, opposite motifs 2 and 1 from class II, as complementary sense and antisense strands of the same ancestral gene.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17386262     DOI: 10.1016/j.molcel.2007.02.010

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  45 in total

1.  Simple yet functional phosphate-loop proteins.

Authors:  Maria Luisa Romero Romero; Fan Yang; Yu-Ru Lin; Agnes Toth-Petroczy; Igor N Berezovsky; Alexander Goncearenco; Wen Yang; Alon Wellner; Fanindra Kumar-Deshmukh; Michal Sharon; David Baker; Gabriele Varani; Dan S Tawfik
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-30       Impact factor: 11.205

2.  Whence the genetic code? Thawing the 'frozen accident'.

Authors:  C W Carter
Journal:  Heredity (Edinb)       Date:  2008-02-13       Impact factor: 3.821

3.  Human tryptophanyl-tRNA synthetase is switched to a tRNA-dependent mode for tryptophan activation by mutations at V85 and I311.

Authors:  Li-Tao Guo; Xiang-Long Chen; Bo-Tao Zhao; Yi Shi; Wei Li; Hong Xue; You-Xin Jin
Journal:  Nucleic Acids Res       Date:  2007-08-28       Impact factor: 16.971

4.  Aminoacylating urzymes challenge the RNA world hypothesis.

Authors:  Li Li; Christopher Francklyn; Charles W Carter
Journal:  J Biol Chem       Date:  2013-07-18       Impact factor: 5.157

Review 5.  Development of tRNA synthetases and connection to genetic code and disease.

Authors:  Paul Schimmel
Journal:  Protein Sci       Date:  2008-09-02       Impact factor: 6.725

6.  On primordial sense-antisense coding.

Authors:  Andrei S Rodin; Sergei N Rodin; Charles W Carter
Journal:  J Mol Evol       Date:  2009-12-03       Impact factor: 2.395

7.  Leucyl-tRNA synthetase editing domain functions as a molecular rheostat to control codon ambiguity in Mycoplasma pathogens.

Authors:  Li Li; Andrés Palencia; Tiit Lukk; Zhi Li; Zaida A Luthey-Schulten; Stephen Cusack; Susan A Martinis; Michal T Boniecki
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-19       Impact factor: 11.205

8.  Functional Class I and II Amino Acid-activating Enzymes Can Be Coded by Opposite Strands of the Same Gene.

Authors:  Luis Martinez-Rodriguez; Ozgün Erdogan; Mariel Jimenez-Rodriguez; Katiria Gonzalez-Rivera; Tishan Williams; Li Li; Violetta Weinreb; Martha Collier; Srinivas Niranj Chandrasekaran; Xavier Ambroggio; Brian Kuhlman; Charles W Carter
Journal:  J Biol Chem       Date:  2015-06-18       Impact factor: 5.157

9.  Mg2+-assisted catalysis by B. stearothermophilus TrpRS is promoted by allosteric effects.

Authors:  Violetta Weinreb; Li Li; Cassandra L Campbell; Laurie S Kaguni; Charles W Carter
Journal:  Structure       Date:  2009-07-15       Impact factor: 5.006

10.  One ancestor for two codes viewed from the perspective of two complementary modes of tRNA aminoacylation.

Authors:  Andrei S Rodin; Eörs Szathmáry; Sergei N Rodin
Journal:  Biol Direct       Date:  2009-01-27       Impact factor: 4.540

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.